I-131 MIBG: payments to doctors
Payments that named I-131 MIBG as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $958K
- Providers
- 1
- Transactions
- 7
- Average per transaction
- $136,909
The per-transaction average — $136,909 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1 providers the average total is $958,363, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Jubilant Draximage Inc. | $958,363 | 100.0% |